ATE314094T1 - Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche - Google Patents

Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche

Info

Publication number
ATE314094T1
ATE314094T1 AT99931090T AT99931090T ATE314094T1 AT E314094 T1 ATE314094 T1 AT E314094T1 AT 99931090 T AT99931090 T AT 99931090T AT 99931090 T AT99931090 T AT 99931090T AT E314094 T1 ATE314094 T1 AT E314094T1
Authority
AT
Austria
Prior art keywords
afp
fetoprotein
alpha
complex
treatment
Prior art date
Application number
AT99931090T
Other languages
German (de)
English (en)
Inventor
Oleg Strelchenok
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of ATE314094T1 publication Critical patent/ATE314094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99931090T 1998-06-17 1999-06-17 Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche ATE314094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802162A SE9802162D0 (sv) 1998-06-17 1998-06-17 Immunostimulating composition
PCT/EP1999/004201 WO1999065936A2 (en) 1998-06-17 1999-06-17 Composition for the treatement of immune deficiencies and methods for its preparation and use

Publications (1)

Publication Number Publication Date
ATE314094T1 true ATE314094T1 (de) 2006-01-15

Family

ID=20411743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931090T ATE314094T1 (de) 1998-06-17 1999-06-17 Ein komplex aus alpha-fetoprotein (afp) und einem polyungesättigten fettsäurederivat zur behandlung von immunschwäche

Country Status (10)

Country Link
US (1) US6599507B2 (enExample)
EP (1) EP1085909B1 (enExample)
JP (1) JP4392991B2 (enExample)
AT (1) ATE314094T1 (enExample)
AU (1) AU748838B2 (enExample)
BR (1) BR9911294B1 (enExample)
CA (1) CA2335079C (enExample)
DE (1) DE69929189T2 (enExample)
SE (1) SE9802162D0 (enExample)
WO (1) WO1999065936A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
SE9900941D0 (sv) * 1998-12-23 1999-03-16 Nomet Management Serv Bv Novel retinoic acid derivatives and their use
JP4515642B2 (ja) * 1999-03-16 2010-08-04 アーデニア・インベストメンツ・リミテッド 多価不飽和脂肪酸誘導体およびその使用
ATE339429T1 (de) * 2000-07-12 2006-10-15 Ardenia Investments Ltd Neue cytotoxische verbindungen und deren verwendung
US20070111936A1 (en) * 2005-11-15 2007-05-17 Vladimir Pak Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
SE9802162D0 (sv) 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
HK1035866A1 (en) 2001-12-14
JP2004500315A (ja) 2004-01-08
BR9911294A (pt) 2002-01-02
US20010034324A1 (en) 2001-10-25
SE9802162D0 (sv) 1998-06-17
EP1085909A2 (en) 2001-03-28
DE69929189T2 (de) 2006-08-31
JP4392991B2 (ja) 2010-01-06
AU4773499A (en) 2000-01-05
US6599507B2 (en) 2003-07-29
WO1999065936A3 (en) 2000-02-10
BR9911294B1 (pt) 2012-01-10
EP1085909B1 (en) 2005-12-28
WO1999065936A2 (en) 1999-12-23
CA2335079A1 (en) 1999-12-23
CA2335079C (en) 2008-01-08
DE69929189D1 (de) 2006-02-02
AU748838B2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
ATE321525T1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
GB9807639D0 (en) Anti-inflammatory agents
DE602004026303D1 (de) Behandlung von entzündlichen erkrankungen
DE60043692D1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
ATE125820T1 (de) Verfahren und zusammensetzungen zur heilung von geschwüren.
DE60000492D1 (de) Kosmetisches Verfahren zur Haarbehandlung mit Metallpartikeln zur Verbesserung des Haarglanzes
DE59807213D1 (de) 11beta-halogen-7alpha-substituierte-estratriene, verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha-substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln
DE69429806D1 (de) Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
ATE330608T1 (de) Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen
DE60216281D1 (de) Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
ATE311871T1 (de) Verwendung von zinksalzen der konjugierten linoleinsäuren zur behandlung von hautkrankheiten
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
IS5505A (is) Notkun á blöndu díóls og alfa-hýdroxýsýru til að meðhöndla sjúkdóma sem lýsa sér í ofvexti í hornlagi húðþekju
DE69929189D1 (de) Ein Komplex aus Alpha-Fetoprotein (AFP) und einem polyungesättigten Fettsäurederivat zur Behandlung von Immunschwäche
DE3468021D1 (en) Imidazol-2-yl mercapto alkanoic acids, process for producing the same and pharmaceutical preparations containing the same
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69838553D1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
EP0956030A4 (en) THERAPEUTIC APPLICATION OF THE T-BAM (CD40L) TECHNIQUE FOR TREATING DISEASES RELATED TO THE CELLS OF THE SMOOTH MUSCULAR SYSTEM
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
DE69003960D1 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties